RG 7641Alternative Names: RG-7641
Latest Information Update: 29 Jul 2015
At a glance
- Originator Roche
- Mechanism of Action Aldosterone synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Kidney disorders
Most Recent Events
- 29 Jul 2015 Discontinued - Phase-I for Kidney disorders in Switzerland (unspecified route)
- 31 Dec 2013 Phase-I clinical trials in Kidney disorders in Switzerland (unspecified route)